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A. SUMMARY 
 
 
 
A.1 Specialty Chemicals 
 
In general, NMS, in comparison to the EU-15, have less specialised production of fine and specialty 
chemicals and account for a relatively small share in the value added of the chemical industry. In this 
respect, the impact of REACH is expected to be relatively less important in the NMS. However, since 
many producers of the non-basic chemicals in NMS do not have the scale of production and a 
relatively secure market position as being the case for their counterparts in EU15, they could face more 
difficulties and be more sensitive to REACH. 
 
A detailed examination of the specialty chemicals sector has been carried out in the three selected 
countries for the case study, i.e. the Czech Republic, Poland and Estonia. The evolution of the sub-
sector appears to be similar in the Czech Republic and Poland. In terms of turnover the specialty 
chemicals production has grown much faster than the chemical sector as a whole and such growth has 
been even more pronounced in terms of value added. In comparison, specialty chemicals contribute 
38% and 24% to the total turnover of the chemical industry in Poland and the Czech Republic 
respectively.  
 
In both countries, export and import of specialty chemicals increased with export increase much faster 
than import. Despite this growth there is still a trade deficit in specialties in both countries that 
amounts to 27% of total chemicals trade deficit in the Czech Republic and to 23% in Poland. 
 
Data show that the chemical sector and specialty chemicals in particular in Estonia have stagnated and 
there has been very slow development in production and productivity. The specialty chemicals sub 
sector takes a prominent position within the chemical industry (50% of sector’s value added). Trade 
with eastern non-EU countries plays a dominant role in this country, especially for specialty chemicals 
(74% export to non EU countries).  
 
Trade with non-EU countries may be particularly affected by REACH. Regarding imports, the need for 
registration of imported raw material and the potential lack of necessary information from the supplier 
might force the importers to switch to EU suppliers. Regarding exports, the price increases of 
chemicals after registration might lower their competitiveness on markets outside the EU. Thus, due to 
its much larger share of exports to non-EU countries and stronger reliance on raw material imports 
from outside the EU, Estonia may be more affected by the implementation of REACH. 
 
A.2 Business case study in selected New Member States 
 
While valuable information has been generated in the course of this work, considerable care has to be 
taken in evaluating the findings in order to avoid any broad-based conclusions in relation to the 
capacity or otherwise of the general body of enterprises in the new Member States to cope with 
REACH. In particular, the limitations of the exercise linked to the time constraints and the difficulty of 
identifying suitable firms willing and capable of early participation, the difficulties in pursuing a full 
supply chain analysis due to issues of confidentiality and which precluded   the involvement of 
downstream users, and the particular characteristics of the participating firms which mainly produced 
high volume substances, do not allow these results to be regarded as representative of the experience in 
the new Member States.  
 
 
A.2.1 Impact on competitiveness  
 
The case studies carried out in this study included 15 companies. Amongst these were 7 manufacturers 
of substances, 2 importers, 5 formulators and 1 downstream user. As the data of the downstream user 
entered the analysis at a very late stage, no thorough analysis could be carried out for this company.  
Chemical companies interviewed and industry associations of the new member states fear that the 
implementation of REACH might increase the competitive pressure on them. The main concerns 
expressed by them are: 
 
• Companies expect increasing cost through testing and registration, without being able to pass 
the costs on through of the supply chain.  
 
• Some companies expressed the worry that potential withdrawal of substances under REACH 
would result in a reduced number of suppliers. This might lead to increased dominance of the 
remaining suppliers and consequently, price increases may exceed the actual REACH cost.  
 
• According to the industry associations many SME, use large numbers of chemicals, often in 
low volumes, and serve profitable niche markets. These companies are considered to be 
vulnerable to REACH because they can not anticipate or avoid decisions from suppliers 
regarding substance withdrawal.  
 
• One of the key concerns of the companies is the administrative efforts required by REACH. 
Companies, may have difficulties to find additional resources to implement REACH. 
According to industry associations this might be particularly a problem for SME: As their 
markets are small and competition is generally high, the formation of consortia, which is one of 
the important cost reduction measures envisaged in REACH, may not be easily achieved. On 
the other hand, branches of multinational companies, although classified as SMEs, are thought 
to be able to manage REACH.  
 
• It is expressed that REACH might result in competitive advantages for EU15 companies and 
may eventually drive local companies out of business. This reflects the currently experienced 
competitive pressure from their EU15 counterparts. 
 
In the frame of this study, for the 7 manufacturers, whose product portfolio comprises 419 substances, 
a vulnerability analysis was carried out, calculating NPV for 29 substances and price increase after 
REACH for 8 imported raw materials. The volume bands for these substances are as follows: 0-10 
tons: 1 substances, 10-100 tons: 10 substances, 100-1000 tons: 5 substances, more than 1000 tons: 21 
substances. One of these substances, with a negative NPV, resulted to be vulnerable. This one, a 
polymer, is used in one of the selected preparations. A further five1 non-polymer substances were non-
profitable in the data reporting year and hence regarded as vulnerable to REACH. For one company 
the one-off cost of registration represented 9.6% of the profits.  
 
With regards to the 5 formulators, for 12 preparations, which were composed of 137 substances, 
vulnerability analysis based on NPV and price increase estimation was carried out. Substantial 
increases in raw material costs could be identified in a few cases. These cases lead to price increases 
between 0.03% and 2% for the 12 analyzed formulations in a full pass-through scenario. Additionally, 
sufficient suppliers for the analysed input substances are available, accordingly no raw material 
shortages can be expected. For some preparations a refreshment or reformulation of the product may 
become necessary. A preparation supplier was found to have significant impact on its profit margin, a 
decrease of 58% due to substance price increases.  
                                                 
1 Three in Estonia and two in Poland 
 
Two importers were analysed in this study, whose import portfolio comprises 148 substances, out of 
which 102 are imported from eastern non-EU countries. Due to scarce data availability, an analysis of 
the product portfolio could only be carried out for the Estonian importer. Compared with the substance 
manufacturers and formulators, the company appears to be more affected by REACH. Analysed data 
show that REACH registration total one-off registration cost represents up to 80% of the company’s 
total one year turnover. The extent of the effect could not be analysed in detail, however, a few 
important findings are worth to discuss. It was shown from the analysed sample that the raw material 
price level in eastern non EU countries is on average 35 % below the cost of material of EU origin. 
Under REACH, the importer would need to invest in registration in order to maintain its non-EU 
imports. The analysis showed that after registration under REACH less than 50% of the imported 
substances assessed from non-EU countries are still cheaper than those of EU origin, thus continuous 
trade of those substances can be maintained by the importer. The rest of the substance would have a 
higher price than that on the EU market, thus the importer may need to switch its supply to EU origin 
(price increase between 40% - 70%). In both cases the price is expected to increase with impacts on 
profit margins and, as whole, changes of the supply network may be expected. 
 
No interviews with downstream user clients of the selected formulators were carried out in the context 
of this study.  
 
A.2.2 Impacts on the product portfolio 
 
In the quantitative analysis of the case studies only a small number of the 29 analyzed substances have 
been identified as vulnerable having a negative NPV. Whether production of these substances will be 
phased out under REACH by the individual manufacturing company will depend on the NPV criteria 
and other factors such as cost pass on and alternatives for cost reduction, e.g. entering consortia for 
registration and sharing of test results, which have not been analysed.  
 
As mentioned, importers are expected to be affected more than manufacturers due to the fact they tend 
to have a broader range of products in the lower tonnage band. Their situation is aggravated by the fact 
that the suppliers of these substances might not be able to provide them with all information which is 
required for registration under REACH. This implies that REACH may result in importers modifying 
its product profile to limit the cost of registration, e.g. mainstreaming product portfolio. Consequently, 
this may reduce the number of suppliers per substance on the market. 
 
A.2.3 Impacts on innovation 
 
In the interviewed companies in Poland and the Czech Republic, the R&D budget stays far below 1 % 
of turnover. In the Estonian average companies spend around 2.7 %. Average in EU-15 is a share of 5 
to 8 %, according to CEFIC. 
 
The analysis of the case studies revealed that in a limited number of cases, prices for substances would 
substantially increase through REACH, in particular in the case of imported raw materials. However, 
raw material availability was in none of the cases endangered, though would be subject to substantial 
price increases of 40-60%. 
 
However, it turns out that the capacity for R&D and innovation in the chemical sector as a whole is 
limited in the NMS when compared to the EU-15. In the single market, this is a strong competitive 
disadvantage in itself, and might also hamper the implementation of REACH.  
 
A.2.4 Impacts on HSE management 
 
The standard of the HSE management seems close to that of the EU-15. This was primarily a 
consequence of the implementation and enforcement of the Chemicals Acquis, which is fairly 
complete. All companies stated that neither big efforts nor excessive costs were necessary for 
compliance. IT aided management systems for bookkeeping and tracing of chemicals are quite 
common, although not 100% available. Company's units for the classification and labelling scheme of 
substances and preparations, as well as the management of SDS are well staffed. Responsible staffs 
have to handle far lower numbers of SDS per person than in EU-15 companies. 
 
Considering the cooperation along the supply chain of chemicals, the situation is similar to that of EU-
15 companies. Support of downstream users of chemicals by the manufacturers of that preparation is 
business as usual. But regular contacts of substance suppliers with downstream users in the 
manufacturing sectors are rare. The establishment and maintenance of such cooperation, which is not 
driven by the operational business, is one of the new challenges coming up with REACH. 
 
The number of testing laboratories is regarded as appropriate for the implementation of the current 
chemicals legislation. Nevertheless it can be foreseen that the need for testing of the phase-in 
substances under REACH cannot be met with the current number of GLP certified laboratories.  
 
A.2.5 Ability of companies to cope with REACH 
 
The analysis confirmed that the knowledge about REACH in the companies of the NMS is 
fragmentary. The priority for preparatory activities for REACH in the interviewed companies is low. 
The reason is not the lack of strategic foresight, but the lack of time and resources due to other more 
urgent challenges which they face, for example, the ongoing privatisation, the restructuring and 
modernisation of production, the efforts to comply with the Environmental Acquis, and the 
dramatically increasing competition with EU-15 companies after accession, which absorb much of the 
companies’ management capacity. The question of relocation to other countries or withdrawal of 
processes and products was not an issue for any of the interviewed companies. Companies have not yet 
assessed impacts of REACH on their own company, nor have they developed strategies to cope with 
the foreseeable changes of the future chemical regulation regime. None of the interviewees were able 
to draw even a rough picture of company's approach to identify substance uses and to perform 
exposure assessments and risk characterisations at downstream users. 
 
After implementation of the Chemicals Acquis, in principle the starting point for REACH 
implementation seems to be at a common level between EU-15 and NMS companies. But, the lack of 
experience, low innovation capacity, a general competitive disadvantage, combined with increasing 
competitive pressure from the EU-15, and the ongoing effort for implementing the heavy investment 
directives under the Environmental Acquis might be drawbacks for the implementation of REACH in 
the New Member States. 
 
 
A.2.6 Business benefits of implementation of REACH 
 
The designed benefits of REACH in terms of environment and health are generally acknowledged by 
the interviewed companies. Business benefits were thought to be possible by many but not considered 
important to the company and the accompanied administrative burden of REACH implementation is 
thought to outweigh the potential benefit. Out of the 13 visited manufacturers, ten companies recognise 
the need to improve information exchange along the value chain and half of them consider the 
implementation of REACH could benefit in this respect. Four companies, including all the interviewed 
manufacturers in Poland, do not see any benefit of REACH. The business benefits of REACH 
implementation are mostly thought to be better credibility and image of companies, as well as risk 
prevention though the availability of more detailed information on substances used in the production. 
